Company news

Share this article:
Revolution Health and EmergingMed announced a partnership to offer a new cancer clinical trial matching service for patients and physicians. “EmergingMed is committed to providing personalized services to patients who are exploring treatment options,” said Courtney Hudson, EmergingMed founder and CEO in a statement. “We believe patients should have access to the latest research options targeting their specific diagnoses.” The service is available for online searching, as well as by telephone.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.